Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Université Toulouse III - Paul Sabatier · Université Fédérale de Toulouse Midi-Pyrénées · +35 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,355
total citations
- FWCI
- 62.43
- Percentile
- 100%
- References
- 37
Citations per year
Authors
38- JMJ. MazieresCorresponding
Université Toulouse III - Paul Sabatier, Université Fédérale de Toulouse Midi-Pyrénées
- ADAlexander Drilon
Memorial Sloan Kettering Cancer Center, Cornell University
- ALAmélie Lusque
Institut Claudius Regaud
- LMLaurent Mhanna
Université Toulouse III - Paul Sabatier
- ABAlexis B. Cortot
Université de Lille
Topics & keywords
Topics
Keywords
- Medicine
- Lung cancer
- Cancer research
- Immune checkpoint
- Oncology
- Cancer
- Immune system
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.